View this email in your browser

IowaBio Monthly Newsletter

March 2021



Note From the Executive Director

We know many of our member companies and our members personally, have been experiencing a great deal of change during the pandemic. IowaBio and our staff is no exception. Melissa Moyer, Associate Director of over ten years, has announced she is leaving IowaBio to take a new position at the Des Moines Partnership. I am sure many of you have made great memories with her over the years. I know I have! We will certainly miss her. She has a developed a vast and varied skillset and her new place of employment is lucky to have her. Melissa’s last day at IowaBio will be March 12. We wish you well Melissa!

IowaBio is seeking to fill her very big shoes, so please circulate this job description at this link for Communications and Events Manager to qualified candidates. Applicants can send a cover letter, resume and references to Jessica Hyland at by March 14.

Thank you to everyone who made IBSC 2021 a success! Our virtual conference, held March 2-3, included our Biotech Showcase Pitch Competition, Biotech Leader Award presentation, and six specialized tracks. We also had a plenary legislative update, past showcase/award winner presentations, and a keynote with Dr. Michelle McMurry-Heath, the new CEO of BIO. It was a great two days where we hope many of you connected, learned and got excited about our Iowa biotech ecosystem! We appreciate our sponsors, speakers judges, and moderators for making it possible, as well as our planning committee members. What a great event!


Thanks Again to our Top Sponsors:
Exclusive opportunity for IowaBio members!

IowaBio members are invited and encouraged to attend our Legislative Update Calls, which will be held at key points during and after session to give you the latest on what’s happening at the Capitol and in your industry.

Calls will be held via Zoom at the dates and times listed below:  
  • Friday, March 5 | 9:30 - 10:00am (Post First Funnel Update)
  • Friday, April 2 | 9:30 - 10:00am (Post Second Funnel Update)
  • Session Wrap-Up Call | Date and Time TBA
If you are a member and would like to attend these calls, please register using the button below:
Register Today

IowaBio welcomes the following new members to our association:

IowaBio thanks the following members for recently renewing:
Corteva Agriscience Researchers Receive 2021 Iowa Biotech Leader Award
The winner of the 2021 Iowa Biotech Leader Award was announced and presented on March 3, 2021, to the team members of Project Upstanding at Corteva Agriscience. This group of Corteva researchers received the award through a call for nominations and was selected by a panel of industry experts. 

Most years, the award recognizes an individual who, in the past year, demonstrated leadership in their organization and within the industry, an ability to bring innovative biotechnology products and services to the marketplace and a commitment to advocate for Iowa’s biotechnology industry. Considering the unique circumstances and challenges brought by COVID-19 over the last year, this year’s selection committee felt it was appropriate think outside the box and offer the award to a team, rather than an individual. 
Learn more >
The Public Health Conference of Iowa
The COVID-19 pandemic has highlighted public health’s leadership role in the safety and security of our communities. To keep public health at the forefront of sharing lessons learned, we are excited to announce the rebranding of Iowa’s premiere annual public health conference. The Public Health Conference of Iowa will be held virtually during National Public Health Week – April 5-9, 2021. This year’s theme is Public Health in Action: Taking on a Pandemic, Health Equity, Natural Disasters and More! The week will consist of keynote speakers, concurrent session presentations from colleagues across the state, poster presentations, wellness breaks, a virtual exhibitor hall, and opportunities to connect virtually with public health friends.
Learn more >
Viewpoint Molecular Targeting™ Awarded $5 Million in Phase II SBIR Grants from the National Institutes of Health - National Cancer Institute
Viewpoint Molecular Targeting, Inc., a radiopharmaceutical company developing precision α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced it has been awarded a total of $5 million in Phase II grants from the National Cancer Institute under the SBIR program and National Institutes of Health (NIH). The grants will be utilized to advance the Company’s proprietary image-guided alpha-particle radiotherapies in development to enable a unique approach to optimize treatment that could potentially improve efficacy and minimize toxicity associated with many other cancer drugs.
Learn more >
IDT Developing PrimeTime™ SARS-CoV-2/Flu Test for Comprehensive Patient Testing
Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, is developing a multiplex RT-qPCR test that can detect and distinguish between SARS-CoV-2, influenza A, and influenza B from a single patient sample. The new PrimeTime™ SARS-CoV-2/Flu Test is being submitted by IDT for U.S. Food and Drug Administration Emergency Use Authorization (EUA).
Learn more >
Cardio Diagnostics Launches Epi+Gen CHD™, A New Heart Disease Risk Assessment Test
Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending flagship product, Epi+Gen CHD. The Epi+Gen CHD test sensitively assesses the risk for the onset of new coronary heart disease, an ability that is key to providing cost-effective health care for adults.
Learn more >
Gross-Wen Technologies receives $2M grant for new algae partner project
Gross-Wen Technologies (GWT), founded by two Iowa State University (ISU) professors, has announced a new partnership with University of California, San Diego (UCSD), the National Renewable Energy Laboratory and Algix to develop carbon-sequestering molecular films to capture carbon dioxide with algae. This new partnership was awarded a $2 million grant from the U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy.
Learn more >
Brazil Patent Allowance for Human Obesity Vaccines to Braasch Biotech
Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Brazilian Intellectual Property Office for Braasch’s patent entitled “Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone Deficiency.”
Learn more >
Science Delivered

Avantor is a globally trusted provider of mission-critical products and services, enabling customers to move science forward, from scientific discovery to scale-up and commercial delivery.  And through VWR®, our premier delivery platform, our customers receive seamless, standardized purchasing and fulfillment and innovative, customizable solutions and services.

Avantor offers a complete solution unique in the life sciences industry:  one company able to fully supply the essential products, systems and solutions, the unmatched expertise and the world-class delivery systems focused on one goal:  to help our customers move science forward.  

One company.  One mission.  That’s science delivered.

For questions or inquiries, please contact Trevor Dettmann at

The Session Bill Tracker is a weekly report issued every Friday during legislative session. It provides an update on state and federal activities as well as a tracking record of bills relevant to the biotech industry and IowaBio’s position. This report is best suited for government affairs representatives and biotech companies engaged in policy efforts. To view archives of this distribution or sign up for the communications, please click here.

Our Monthly Newsletter is a great resource to keep up with IowaBio's activities, member and industry news, as well as additional savings, educational and networking opportunities in your area and across the globe. To view archives of this distribution or sign up for the newsletter, please click here

Starting March 23rd, IowaBio began issuing daily updates to share the latest news surrounding the virus from the biotech industry's point of view. Topics covered include state, national and global updates, legislative activities on the state and federal level, IowaBio member efforts and innovations, helpful resources/media and more. To view archives of this distribution or sign up for the communications, please click here
Copyright © 2019 Iowa Biotechnology Association, All rights reserved.

Our mailing address is:
500 E Court Avenue, Suite 112
Des Moines, IA 50309-2057

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.